Testing effectiveness (Phase 2)Study completedNCT01575860What this trial is testingMaintenance Lenalidomide in LymphomaWho this might be right forLymphoma Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Study completedNCT03436862What this trial is testingNivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression RiskWho this might be right forHodgkin Lymphoma SCRI Development Innovations, LLC 37
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT04601831What this trial is testing'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHLWho this might be right forNon-Hodgkin Lymphoma University of Texas Southwestern Medical Center 14
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Large-scale testing (Phase 3)Ended earlyNCT05664217What this trial is testingNKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell LymphomaWho this might be right forNon-Hodgkin LymphomaRelapsed/Refractory Diffuse Large B-cell Lymphoma Nektar Therapeutics 15
Testing effectiveness (Phase 2)Study completedNCT00003963What this trial is testingChemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell TransplantationWho this might be right forLymphoma Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03480334What this trial is testingAbscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 TherapyWho this might be right forClassical Hodgkin Lymphoma University of Cologne 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06723457What this trial is testingEpcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Polymorphic Post-Transplant Lymphoproliferative DisorderRefractory B-Cell Non-Hodgkin Lymphoma Northwestern University 34
Early research (Phase 1)Study completedNCT01588015What this trial is testingVaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Testing effectiveness (Phase 2)UnknownNCT04337606What this trial is testingChidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen ReceptorWho this might be right forNon Hodgkin Lymphoma Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT01822509What this trial is testingIpilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell TransplantWho this might be right forAllogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Ended earlyNCT00121186What this trial is testingS0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03075696What this trial is testingA Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 940
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT01556035What this trial is testingLenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous LymphomaWho this might be right forRefractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) University Hospital, Bordeaux 19
Testing effectiveness (Phase 2)Ended earlyNCT02259348What this trial is testingRepeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 12